Cargando…
Improving safety and efficacy with pharmacist medication reconciliation in orthopedic joint surgery within an enhanced recovery after surgery program
PURPOSE: To investigate the impact of medication reconciliation (MR), through avoidance of unintentional medication discrepancies, on enhanced recovery after surgery programs designed for older patients undergoing orthopedic joint surgery. METHOD: Our study was divided into two phases. In the first...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8985260/ https://www.ncbi.nlm.nih.gov/pubmed/35387676 http://dx.doi.org/10.1186/s12913-022-07884-9 |
_version_ | 1784682331042217984 |
---|---|
author | Zheng, Xiaoying Xiao, Lei Li, Ying Qiu, Feng Huang, Wei Li, Xinyu |
author_facet | Zheng, Xiaoying Xiao, Lei Li, Ying Qiu, Feng Huang, Wei Li, Xinyu |
author_sort | Zheng, Xiaoying |
collection | PubMed |
description | PURPOSE: To investigate the impact of medication reconciliation (MR), through avoidance of unintentional medication discrepancies, on enhanced recovery after surgery programs designed for older patients undergoing orthopedic joint surgery. METHOD: Our study was divided into two phases. In the first phase, MR was performed for elderly patients undergoing orthopedic joint surgery. Types of medication discrepancies and their potential risks were analyzed. In the second phase, a controlled study was conducted in a subgroup of patients diagnosed with periprosthetic joint infection (PJI) and who were scheduled for two-stage revision. The primary goal was to investigate the impact of MR on length of stay for the first stage. The secondary goal was to investigate the time between the first admission and the reimplantation of a new prosthesis, the number of readmissions within 30 days, hospitalization cost. RESULTS: A total of 506 medication discrepancies were identified in the included 260 patients. Intolerance had the highest incidence (n = 131, 25.7%). The Bayliff tool showed that 71.9% were assessed as level 2 risk, and 10.3% had a life-threatening risk. For patients with PJI, MR reduced the average length of stay in the first stage (16.3 days vs. 20.7 days, P = 0.03) and shortened the time (57.3 days vs. 70.5 days, P = 0.002) between the first admission and the reimplantation of a new prosthesis. The average cost of hospital stay ($8589.6 vs. $10,422.6, P = 0.021), antibiotics ($1052.2 vs. $1484.7, P = 0.032) and other medications ($691.5 vs. $1237.6, P = 0.014) per patient at our hospital were significantly decreased. Notably, significant improvements in patient satisfaction were seen in participants in the MR group. CONCLUSION: Through MR by clinical pharmacists, medication discrepancies within the orthopedic ERAS program could be identified. For patients with periprosthetic joint infection, better patient satisfaction and clinical and economical outcomes can be achieved with this method. |
format | Online Article Text |
id | pubmed-8985260 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-89852602022-04-07 Improving safety and efficacy with pharmacist medication reconciliation in orthopedic joint surgery within an enhanced recovery after surgery program Zheng, Xiaoying Xiao, Lei Li, Ying Qiu, Feng Huang, Wei Li, Xinyu BMC Health Serv Res Research PURPOSE: To investigate the impact of medication reconciliation (MR), through avoidance of unintentional medication discrepancies, on enhanced recovery after surgery programs designed for older patients undergoing orthopedic joint surgery. METHOD: Our study was divided into two phases. In the first phase, MR was performed for elderly patients undergoing orthopedic joint surgery. Types of medication discrepancies and their potential risks were analyzed. In the second phase, a controlled study was conducted in a subgroup of patients diagnosed with periprosthetic joint infection (PJI) and who were scheduled for two-stage revision. The primary goal was to investigate the impact of MR on length of stay for the first stage. The secondary goal was to investigate the time between the first admission and the reimplantation of a new prosthesis, the number of readmissions within 30 days, hospitalization cost. RESULTS: A total of 506 medication discrepancies were identified in the included 260 patients. Intolerance had the highest incidence (n = 131, 25.7%). The Bayliff tool showed that 71.9% were assessed as level 2 risk, and 10.3% had a life-threatening risk. For patients with PJI, MR reduced the average length of stay in the first stage (16.3 days vs. 20.7 days, P = 0.03) and shortened the time (57.3 days vs. 70.5 days, P = 0.002) between the first admission and the reimplantation of a new prosthesis. The average cost of hospital stay ($8589.6 vs. $10,422.6, P = 0.021), antibiotics ($1052.2 vs. $1484.7, P = 0.032) and other medications ($691.5 vs. $1237.6, P = 0.014) per patient at our hospital were significantly decreased. Notably, significant improvements in patient satisfaction were seen in participants in the MR group. CONCLUSION: Through MR by clinical pharmacists, medication discrepancies within the orthopedic ERAS program could be identified. For patients with periprosthetic joint infection, better patient satisfaction and clinical and economical outcomes can be achieved with this method. BioMed Central 2022-04-06 /pmc/articles/PMC8985260/ /pubmed/35387676 http://dx.doi.org/10.1186/s12913-022-07884-9 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Zheng, Xiaoying Xiao, Lei Li, Ying Qiu, Feng Huang, Wei Li, Xinyu Improving safety and efficacy with pharmacist medication reconciliation in orthopedic joint surgery within an enhanced recovery after surgery program |
title | Improving safety and efficacy with pharmacist medication reconciliation in orthopedic joint surgery within an enhanced recovery after surgery program |
title_full | Improving safety and efficacy with pharmacist medication reconciliation in orthopedic joint surgery within an enhanced recovery after surgery program |
title_fullStr | Improving safety and efficacy with pharmacist medication reconciliation in orthopedic joint surgery within an enhanced recovery after surgery program |
title_full_unstemmed | Improving safety and efficacy with pharmacist medication reconciliation in orthopedic joint surgery within an enhanced recovery after surgery program |
title_short | Improving safety and efficacy with pharmacist medication reconciliation in orthopedic joint surgery within an enhanced recovery after surgery program |
title_sort | improving safety and efficacy with pharmacist medication reconciliation in orthopedic joint surgery within an enhanced recovery after surgery program |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8985260/ https://www.ncbi.nlm.nih.gov/pubmed/35387676 http://dx.doi.org/10.1186/s12913-022-07884-9 |
work_keys_str_mv | AT zhengxiaoying improvingsafetyandefficacywithpharmacistmedicationreconciliationinorthopedicjointsurgerywithinanenhancedrecoveryaftersurgeryprogram AT xiaolei improvingsafetyandefficacywithpharmacistmedicationreconciliationinorthopedicjointsurgerywithinanenhancedrecoveryaftersurgeryprogram AT liying improvingsafetyandefficacywithpharmacistmedicationreconciliationinorthopedicjointsurgerywithinanenhancedrecoveryaftersurgeryprogram AT qiufeng improvingsafetyandefficacywithpharmacistmedicationreconciliationinorthopedicjointsurgerywithinanenhancedrecoveryaftersurgeryprogram AT huangwei improvingsafetyandefficacywithpharmacistmedicationreconciliationinorthopedicjointsurgerywithinanenhancedrecoveryaftersurgeryprogram AT lixinyu improvingsafetyandefficacywithpharmacistmedicationreconciliationinorthopedicjointsurgerywithinanenhancedrecoveryaftersurgeryprogram |